Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma

BACKGROUND: Several randomised clinical trials have studied convalescent plasma for coronavirus disease 2019 (COVID-19) using different protocols, with different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralising antibody titres, at different time-points and severities of illn...

Descripción completa

Detalles Bibliográficos
Autores principales: Devos, Timothy, Van Thillo, Quentin, Compernolle, Veerle, Najdovski, Tomé, Romano, Marta, Dauby, Nicolas, Jadot, Laurent, Leys, Mathias, Maillart, Evelyne, Loof, Sarah, Seyler, Lucie, Moonen, Martial, Moutschen, Michel, Van Regenmortel, Niels, Ariën, Kevin K., Barbezange, Cyril, Betrains, Albrecht, Garigliany, Mutien, Engelen, Matthias M., Gyselinck, Iwein, Maes, Piet, Schauwvlieghe, Alexander, Liesenborghs, Laurens, Belmans, Ann, Verhamme, Peter, Meyfroidt, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576805/
https://www.ncbi.nlm.nih.gov/pubmed/34446469
http://dx.doi.org/10.1183/13993003.01724-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576805/
https://www.ncbi.nlm.nih.gov/pubmed/34446469
http://dx.doi.org/10.1183/13993003.01724-2021

Ejemplares similares